Trulieve Applauds Trump Administration For Rescheduling Medical Marijuana to Schedule III

Reclassification Enables Research and Supports State Licensed Medical Marijuana Operators  TALLAHASSEE, Fla., April 23, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.